PREVALENCE OF DIFFERENT HEPATITIS B VIRUS GENOTYPES AND RISK FACTORS ASSOCIATED AMONG SELECTED YEMENI PATIENTS WITH CHRONIC HEPATITIS B INFECTION

  • Eman Mohammad Al-Shawkany Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University, Yemen.
  • Abdul-Al-Raoof Mohammad AlShawkany Molecular Genetics Department, College of Veterinary Medicine, Sana`a University, Yemen.
  • Saleh S Bahaj Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University, Yemen.
  • Arwa Mohammed Othman Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University, Yemen.
  • Hassan A Al-Shamahy Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University, Yemen
  • Azhar Azher Mohammed Al-Ankoshy Departement of physiology, Jabir Ibn Hayyan Medical University, Faculty of Medicine/Iraq.
10.22270/ujpr.v6i3.603

Keywords:

chronic hepatitis B, HBV genotype, nested-PCR, prevalence, Yemen

Abstract

Background and aims: Hepatitis B virus infection is a significant public health crisis global. Hepatitis B virus genotyping is an important tool in epidemiological studies to determine the category and extent of treatment and to predict the outcome of chronic infections, for instance hepatocellular carcinoma and cirrhosis. The study designed to determine the prevalence of hepatitis B virus genotypes among Yemeni patients with chronic hepatitis B (CHB) and to evaluate some of the associated risk factors.

Methods: Fifty patients (38 males, 12 females) with chronic hepatitis B from Al-Thawra Modern General Hospital, Al-Kuwait University Hospital, and AL-Gomhoria Hospital were included. HBV DNA was first detected by conventional PCR then HBV genotypes were determined using nested and multiplex PCR. 

Results: Mixed HBV genotypes (A+B+C+D+E), (A+B+C+D+E+F), and  (A+B+C+D)  were found to be the most prevalent (60 %), it is followed by genotype D (16 %), genotype B (16%) and genotype A (8%), whereas C, E, and F genotype were not found individually among the study population. Blood transfusion was associated with mixed infection (χ2=13.06; p= 0.005).

Conclusions: In assumption, this study demonstrates the general prevalence of hepatitis B virus genotypes among HBV-infected Yemeni hepatitis B patients who request medical consideration in a hospital. In mono-genotype HBV infection, genotype B and D were the most prevalent genotypes. In HBV mixed genotype infection, the A/B/C/D/E genotype was the most prevalent in the study area. In the future, based on genotype, clinical trials and treatment regimens must be individually assumed to efficiently manage chronic HBV infection. To this end, a prospective nationwide population study of HBV genotype spreading and clinical outcomes is suggested.

                   r45.gif

Peer Review History:

Received: 2 April 2021; Revised: 5 May; Accepted: 9 June; Available online: 15 July 2021

Academic Editor: 

Ahmad Najiborcid22.jpg, Universitas Muslim Indonesia, Makassar, Indonesia, ahmad.najib@umi.ac.id

Received file:blue_23983.gif                Reviewer's Comments:download_logo_r_29189.gif

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 7.5/10

Reviewer(s) detail:

Dr. Salfarina Ramliorcid22.jpg,  Department of Pharmacology and Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Teknologi MARA, 42300 Puncak Alam, Selangor, Malaysia. salfarina2892@uitm.edu.my  

Dr. Asia Selman Abdullahorcid22.jpg, University of Basrah, Iraq, asia_abdullah65@yahoo.com

Downloads

Download data is not yet available.
Crossmark
Statistics
327 Views | 209 Downloads
Dimension Citations

Published

2021-07-15

How to Cite

Al-Shawkany, E. M., A.-A.-R. M. AlShawkany, S. S. Bahaj, A. M. Othman, H. A. Al-Shamahy, and A. A. M. Al-Ankoshy. “PREVALENCE OF DIFFERENT HEPATITIS B VIRUS GENOTYPES AND RISK FACTORS ASSOCIATED AMONG SELECTED YEMENI PATIENTS WITH CHRONIC HEPATITIS B INFECTION”. Universal Journal of Pharmaceutical Research, vol. 6, no. 3, July 2021, doi:10.22270/ujpr.v6i3.603.

Issue

Section

Research Articles
Share |

Most read articles by the same author(s)

<< < 1 2 3 > >>